Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Advances in Pharmacology (San Diego, Calif.)|October 14, 2014
Delivery of therapeutic peptides and proteins to the CNSTherese S Salameh, William A Banks
Proceedings. Biological Sciences|November 30, 2012
Songbird frequency selectivity and temporal resolution vary with sex and seasonMegan D Gall, Therese S Salameh, Jeffrey R Lucas
Experimental Neurology|December 1, 2018
Routes for the delivery of insulin to the central nervous system: A comparative reviewElizabeth M Rhea, Therese S Salameh, William A Banks
The AAPS Journal|March 25, 2015
Intranasal Delivery of Proteins and Peptides in the Treatment of Neurodegenerative DiseasesM Elizabeth Meredith, Therese S Salameh, William A Banks
Biochemical Pharmacology|August 7, 2020
Brain uptake pharmacokinetics of incretin receptor agonists showing promise as Alzheimer's and Parkinson's disease therapeuticsTherese S Salameh, Elizabeth M Rhea, Konrad Talbot, et al.
Experimental Biology and Medicine (Maywood, N.J.)|July 30, 2016
Insulin resistance, dyslipidemia, and apolipoprotein E interactions as mechanisms in cognitive impairment and Alzheimer's diseaseTherese S Salameh, Elizabeth M Rhea, William A Banks, et al.
Experimental Biology and Medicine (Maywood, N.J.)|November 25, 2017
Gut reactions: How the blood-brain barrier connects the microbiome and the brainAric F Logsdon, Michelle A Erickson, Elizabeth M Rhea, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 13, 2016
Blood-Brain Barrier Disruption and Neurovascular Unit Dysfunction in Diabetic Mice: Protection with the Mitochondrial Carbonic Anhydrase Inhibitor TopiramateTherese S Salameh, Gul N Shah, Tulin O Price, et al.
Molecular Metabolism|October 9, 2018
Ghrelin transport across the blood-brain barrier can occur independently of the growth hormone secretagogue receptorElizabeth M Rhea, Therese S Salameh, Sarah Gray, et al.
Fluids and Barriers of the CNS|January 9, 2019
Disruption of the hippocampal and hypothalamic blood-brain barrier in a diet-induced obese model of type II diabetes: prevention and treatment by the mitochondrial carbonic anhydrase inhibitor, topiramateTherese S Salameh, William G Mortell, Aric F Logsdon, et al.
Pageof 2